Hormone News and Research

RSS

A hormone is a chemical released by one or more cells that affects cells in other parts of the organism. Only a small amount of hormone is required to alter cell metabolism. It is essentially a chemical messenger that transports a signal from one cell to another.

Sperm-busting male contraceptive pill in the pipeline

Scientists are in the process of developing a male contraceptive drug which stops the development process of sperm.

30 Oct 2006

Top doc rushed patients into sex change surgery

One of Britain's top psychiatrists has been brought before the General Medical Council (GMC) over allegations about his fitness to practice.

26 Oct 2006

Confusion abounds on how to treat the menopause

The results in 2002 of a large U.S. study on hormone replacement therapy (HRT) in many respects left women confused and alarmed about the treatment for the menopause.

25 Oct 2006

Mobile phones increase mens' risk of infertility

More doubt has been cast on the safety of mobile phones by a new study which says men who use them could be risking their fertility.

24 Oct 2006

Overweight women more likely to have polycystic ovary syndrome

Overweight and obese Spanish women appear five times as likely as lean women to have polycystic ovary syndrome, a condition that decreases fertility and contributes to other illnesses, according to an article in the October 23 issue of Archives of Internal Medicine.

23 Oct 2006

New findings strengthen link between testosterone levels and health of older men

Low testosterone levels may be associated with a higher risk of falling in older men, according to a report in the October 23 issue of Archives of Internal Medicine.

23 Oct 2006

Wall Street Journal examines debate over alternative HRT to treat menopausal symptoms

The Wall Street Journal on Saturday examined the debate over the risks and efficacy of alternatives to hormone replacement therapy for treatment of menopausal symptoms.

23 Oct 2006

FDA approves Omnaris, new hay fever drug

The U.S. Food and Drug Administration (FDA) has announced the approval of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as hay fever, in adults and children 12 years of age and older.

23 Oct 2006

Squalenoyl nanomedicines as potential therapeutics

Nucleoside analogs such as cytarabine and gemcitabine are powerful anticancer agents, but a simple chemical modification that causes them to assemble into stable nanoparticles could make them even more valuable in the treatment of a wide variety of cancers.

23 Oct 2006

Targeted tumor therapy has paramount consequences for future expansion of nuclear medicine

Targeted tumor therapy lobs toxic payloads directly into tumors to destroy cancer cells while leaving normal cells unharmed.

20 Oct 2006

Psychiatrist in the UK up on 10 charges regarding sex change patients

A psychiatrist in Britain well known for dealing with issues of gender has been brought before the General Medical Council (GMC) on 10 charges of serious professional misconduct with regard to his treatment of patients.

19 Oct 2006

Contraceptive options in the U.S. examined

The New York Times on Tuesday examined contraceptive options in the U.S., where 60% of unplanned pregnancies occur among women who use contraception.

17 Oct 2006

Vitamin D may slow down breast cancer

The authors of a new study are suggesting that vitamin D may slow down the progression of breast cancer.

17 Oct 2006

Judge declares mistrial in case against Wyeth's Prempro

A judge in a Pennsylvania state court in Philadelphia on Wednesday declared a mistrial in a case in which a jury ruled that the use of Wyeth's combination hormone replacement therapy Prempro in part caused breast cancer to develop in a 66-year-old woman, the Wall Street Journal reports.

16 Oct 2006

Roche asks European Medicines Agency for authorization to market Herceptin

Roche on Friday announced it has submitted an application with the European Medicines Agency to market its breast cancer drug Herceptin as a treatment for women living with an aggressive form of advanced-stage breast cancer, called HER2-positive, and hormone receptor-positive breast cancer, AFX/Forbes reports (AFX/Forbes, 10/13).

16 Oct 2006